An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

Section 1. Policy. The United States is a global leader in financial innovation, driven in part by the rapid growth of financial technology (fintech) firms. These firms provide innovative services and ...

WASHINGTON — Secretary of the Army Dan Driscoll and leaders from Anduril, Boeing, General Dynamics, L3Harris, Leidos, Lockheed Martin, Northrop Grumman, Palantir, Perennial Autonomy and RTX announced ...

AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...

A Revolution Medicines drug helped pancreatic cancer patients live nearly six months longer compared to those treated with standard of care chemotherapy, meeting the goals of a pivotal study in this ...

LEXINGTON, Ky. (LEX18) — Hundreds of people gathered at the Laborer's Union in Lexington building to protest the University of Kentucky's "Integrate Blue" plan, which would merge nearly 20 ...

FRANKFURT, March 19 (Reuters) - The Middle East war is an economic drag for Europe and should serve as a wake-up call ‌for more integration, including joint debt issuance, to build up the bloc's ...

Lasting damage to Ras Laffan Industrial City, the world’s largest liquefied natural gas export plant, would have big consequences for the global energy market. By Raja Abdulrahim Reporting from Dubai ...

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...